<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now? — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?</h2>
    <div class="badge">2025-09-15T15:08:00+00:00</div>
    <ul>
      <li>In 2025, Lilly expects to record revenues in the range of $60.0 billion to $62.0 billion, indicating an impressive year-over-year growth of more than 30% We believe that LLY has solid growth prospects and a promising por</li>
<li>Mounjaro and Zepbound account for around 50% of the company’s total revenues.</li>
<li>Lilly’s stock is up 18% since the second-quarter results, easing some of the recent negative sentiment.</li>
<li>Competition Heating Up in the Obesity Space The obesity market is expected to expand to $100 billion by 2030, according to data from Goldman Sachs, which means fierce competition is inevitable.</li>
<li>In 2025, it announced three M&amp;A deals.</li>
<li>LLY’s Stock Price, Valuation and Estimates Lilly’s stock has declined 2.2% so far this year compared with the industry’s decrease of 0.2%.</li>
<li>In the ATTAIN-2 study in obese adults with type II diabetes, the highest dose (36 mg) of orforglipron delivered a weight loss of up to an average of 22.9 pounds or 10.5%.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Lilly%20Moves%20Past%2050-Day%20SMA%3A%20Should%20You%20Consider%20Buying%20the%20Stock%20Now%3F%0A%E2%80%A2%20In%202025%2C%20Lilly%20expects%20to%20record%20revenues%20in%20the%20range%20of%20%2460.0%20billion%20to%20%2462.0%20billion%2C%20indicating%20an%20impressive%20year-over-year%20growth%20of%20more%20than%2030%25%20We%20believe%20that%20LLY%20has%20solid%20growth%20prospects%20and%20a%20promising%20por%0A%E2%80%A2%20Mounjaro%20and%20Zepbound%20account%20for%20around%2050%25%20of%20the%20company%E2%80%99s%20total%20revenues.%0A%E2%80%A2%20Lilly%E2%80%99s%20stock%20is%20up%2018%25%20since%20the%20second-quarter%20results%2C%20easing%20some%20of%20the%20recent%20negative%20sentiment.%0A%E2%80%A2%20Competition%20Heating%20Up%20in%20the%20Obesity%20Space%20The%20obesity%20market%20is%20expected%20to%20expand%20to%20%24100%20billion%20by%202030%2C%20according%20to%20data%20from%20Goldman%20Sachs%2C%20which%20means%20fierce%20competition%20is%20inevitable.%0A%E2%80%A2%20In%202025%2C%20it%20announced%20three%20M%26A%20deals.%0A%E2%80%A2%20LLY%E2%80%99s%20Stock%20Price%2C%20Valuation%20and%20Estimates%20Lilly%E2%80%99s%20stock%20has%20declined%202.2%25%20so%20far%20this%20year%20compared%20with%20the%20industry%E2%80%99s%20decrease%20of%200.2%25.%0A%E2%80%A2%20In%20the%20ATTAIN-2%20study%20in%20obese%20adults%20with%20type%20II%20diabetes%2C%20the%20highest%20dose%20%2836%20mg%29%20of%20orforglipron%20delivered%20a%20weight%20loss%20of%20up%20to%20an%20average%20of%2022.9%20pounds%20or%2010.5%25.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Flilly-moves-past-50-day-sma-should-you-consider-buying-the-stock-now%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/lilly-moves-past-50-day-150800320.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>